APOE and atherosclerosis: The investigation of human platelet activation upon in vitro exposure to oxidized phospholipids and atherosclerosis development in ApoE-deficient mice suggested that the platelet CD36 signaling pathway is involved in ROS accumulation through NAD phosphate oxidase 2, leading to platelet activation, insensitivity to PGI2, and thrombus formation [234,235,236].